ludiomil
novartis biociencias s.a - cloridrato de maprotilina - antidepressivos
ludiomil 25 mg, comprimé pelliculé
amdipharm ltd - chlorhydrate de maprotiline 25 mg - comprimé - 25 mg - pour un comprimé > chlorhydrate de maprotiline 25 mg - inhibiteur non selectif de - classe pharmacothérapeutique - code atc : n06aa21 - inhibiteur non selectif de la recapture de la monoamineludiomil 25 mg, comprimé pelliculé contient la substance active chlorhydrate de maprotiline. ce médicament est antidépresseur.il est indiqué: dans les épisodes dépressifs.
ludiomil 75 mg, comprimé pelliculé
amdipharm ltd - maprotiline (chlorhydrate de) 75 mg - comprimé - 75 mg - pour un comprimé > maprotiline (chlorhydrate de 75 mg - inhibiteur non selectif de - classe pharmacothérapeutique - code atc : n06aa21 - inhibiteur non selectif de la recapture de la monoamineludiomil 75 mg, comprimé pelliculé contient la substance active chlorhydrate de maprotiline. ce médicament est antidépresseur.il est indiqué: dans les épisodes dépressifs.
ludiomil
aft pharmaceuticals ltd - maprotiline hydrochloride 25mg; - film coated tablet - 25 mg - active: maprotiline hydrochloride 25mg excipient: calcium phosphate colloidal silicon dioxide hypromellose iron oxide red iron oxide yellow lactose monohydrate magnesium stearate maize starch polysorbate 80 purified talc stearic acid titanium dioxide - depression endogenous and late-onset (involutional) depression. psychogenic, reactive, and neurotic depression, exhaustion depression. somatogenic depression masked depression menopausal depression other depressive mood disorders characterised by anxiety, dysphoria, or irritability; apathetic states(especially in the elderly); psychosomatic and somatic symptoms with underlying depression and/or anxiety the diagnostic and statistical manual of mental disorders (dsm-iv-tr) and the international statistical classification of diseases and related health problems (icd-10) are standard classifications of mental disorders used by mental health professionals and describe the above mentioned disorders as follows: treatment of depressive episodes, recurrent depressive disorder or major depression.
ludiomil
aft pharmaceuticals ltd - maprotiline hydrochloride 75mg; - film coated tablet - 75 mg - active: maprotiline hydrochloride 75mg excipient: calcium phosphate colloidal silicon dioxide hypromellose iron oxide red iron oxide yellow lactose monohydrate magnesium stearate maize starch polysorbate 80 purified talc stearic acid titanium dioxide - depression endogenous and late-onset (involutional) depression. psychogenic, reactive, and neurotic depression, exhaustion depression. somatogenic depression masked depression menopausal depression other depressive mood disorders characterised by anxiety, dysphoria, or irritability; apathetic states(especially in the elderly); psychosomatic and somatic symptoms with underlying depression and/or anxiety the diagnostic and statistical manual of mental disorders (dsm-iv-tr) and the international statistical classification of diseases and related health problems (icd-10) are standard classifications of mental disorders used by mental health professionals and describe the above mentioned disorders as follows: treatment of depressive episodes, recurrent depressive disorder or major depression.
ludiomil
amdipharm ltd - maprotilina - maprotilina
ludiomil 25 mg filmovertrukne tabletter
amdipharm limited - maprotilinhydrochlorid - filmovertrukne tabletter - 25 mg
ludiomil 75 mg filmovertrukne tabletter
amdipharm limited - maprotilinhydrochlorid - filmovertrukne tabletter - 75 mg
ludiomil 25 mg filmdragerad tablett
amdipharm limited - maprotilinhydroklorid - filmdragerad tablett - 25 mg - maprotilinhydroklorid 25 mg aktiv substans; laktosmonohydrat hjälpämne - maprotilin
ludiomil 75 mg filmdragerad tablett
amdipharm limited - maprotilinhydroklorid - filmdragerad tablett - 75 mg - maprotilinhydroklorid 75 mg aktiv substans; laktosmonohydrat hjälpämne - maprotilin